GENETHON
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1990-01-01
- Employees
- 501
- Market Cap
- -
- Website
- http://www.genethon.fr
Gene Therapy for WAS
Phase 1
Completed
- Conditions
- First Posted Date
- 2011-05-04
- Last Posted Date
- 2018-05-22
- Lead Sponsor
- Genethon
- Target Recruit Count
- 5
- Registration Number
- NCT01347346
- Locations
- 🇫🇷
Hôpital Necker-Enfants Malades, Paris, France
Gene Therapy for Wiskott-Aldrich Syndrome (WAS)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-05-04
- Last Posted Date
- 2021-06-03
- Lead Sponsor
- Genethon
- Target Recruit Count
- 6
- Registration Number
- NCT01347242
- Locations
- 🇬🇧
Royal Free Hospital, London, United Kingdom
🇬🇧Great Ormond Street Hospital, London, United Kingdom
Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-04-29
- Last Posted Date
- 2011-04-29
- Lead Sponsor
- Genethon
- Target Recruit Count
- 9
- Registration Number
- NCT01344798
- Locations
- 🇫🇷
Hôpital Pitié-Salpêtrière, Paris, France
© Copyright 2024. All Rights Reserved by MedPath